aTyr Pharma | LIFE - Ebit


aTyr Pharma reported $-121.47K in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Ardelyx USD -30.68M 35.78M Mar/2026
aTyr Pharma USD -121.47K 24.59M Mar/2026
Biogen USD 419.5M 663.3M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Cipla INR 10.43B 1.55B Sep/2026
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -9.02M 65.06M Mar/2026
CSL USD 2.64B 116M Dec/2025
Curis USD -11.52M 3.64M Mar/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
Grifols EUR 320.55M 91.01M Dec/2025
Lakefront Biotherapeutics EUR -43.51M 20.19M Jun/2026
Novartis USD 4.73B 549M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
United Therapeutics USD 375.6M 49.8M Jun/2026